Schools’ progress in fighting chronic absenteeism has slowed over the past few years, remaining stubbornly higher than ...

Vanderbilt went from 61% to 4.7% acceptance in 25 years — if you’re still treating it as a safety school, you're already ...

Researchers found that the risk of type 2 diabetes varies among young adults. Those with high fasting glucose who qualified ...

Week Study to Evaluate One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults CAMBRIDGE, Mass., March 18, 2026 ...

The 7 mg dose of OV329 demonstrated favorable safety and tolerability profile, reinforcing best-in-category potential for ...

A one-size-fits-all approach to prediabetes treatment may miss the opportunity to implement an early, more intensive, ...

Positive interim Phase 1 data of NEK7-directed MGD MRT-8102 demonstrated profound CRP reductions in elevated CVD-risk subjects; readout of expanded part 3 CRP PoC trial (now called GFORCE-1) anticipat ...

A commentary by FDA officials Vinay Prasad, MD, MPH, and Martin Makary, MD, MPH, details the new system for drug approvals in the US. FDA Commissioner Martin Makary, MD, MPH, and his top deputy Vinay ...

Find out what happened on Day 3 of Pre-Season Testing 1 in Bahrain, and get the thoughts of McLaren Mastercard Formula 1 driver Oscar Piastri and Team Principal Andrea Stella. McLaren Mastercard ...

Find out what happened on Day 2 of Pre-Season Testing 1 in Bahrain, and get the thoughts of McLaren Mastercard Formula 1 driver Lando Norris and Technical Director Neil Houldey. McLaren Mastercard ...

SAN FRANCISCO, Feb 11 (Reuters) - Among early users of Novo Nordisk's (NOVOb.CO), opens new tab new Wegovy weight-loss pill, 36% had no prior experience taking a GLP-1 medication, a new nationwide ...

Reigning world champion Lando Norris finished the first public day of Formula 1 testing in 2026 fastest at the Bahrain International Circuit. The McLaren driver set a benchmark time of a 1:34.669s to ...